RecruitingPhase 3NCT06882564

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Al-Mustansiriyah University
Principal Investigator
NOOR AA TAHER, B.D.S
Al-Mustansiriyah University
Intervention
resveratrol mouthwash(drug)
Enrollment
54 enrolled
Eligibility
20-24 years · All sexes
Timeline
2025 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06882564 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials